Edward P. Feener, CHIEF SCIENTIFIC OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 56,276 shares at $14.04 ($791K) on 2024-02-20, disclosed to the SEC on 2024-02-21.
Scheduled sale ($791k) by CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.04 | 19,591 | $275K | 34.8% |
| 2 | $14.04 | 19,591 | $275K | 34.8% |
| 3 | $14.11 | 8,397 | $118K | 15.0% |
| 4 | $14.11 | 8,397 | $118K | 15.0% |
| 5 | $14.72 | 300 | $4K | 0.6% |
| Total | $14.06 avg | 56,276 |
| $791K |
| 100% |
| Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |
| KALV | SELL | 2023-11-21 | $41K | — | Filing → |